1. Home
  2. CALC vs LTRN Comparison

CALC vs LTRN Comparison

Compare CALC & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • LTRN
  • Stock Information
  • Founded
  • CALC 2011
  • LTRN 2013
  • Country
  • CALC United States
  • LTRN United States
  • Employees
  • CALC N/A
  • LTRN N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • LTRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CALC Health Care
  • LTRN Health Care
  • Exchange
  • CALC Nasdaq
  • LTRN Nasdaq
  • Market Cap
  • CALC 36.0M
  • LTRN 33.7M
  • IPO Year
  • CALC N/A
  • LTRN 2020
  • Fundamental
  • Price
  • CALC $2.51
  • LTRN $5.01
  • Analyst Decision
  • CALC Strong Buy
  • LTRN Hold
  • Analyst Count
  • CALC 5
  • LTRN 1
  • Target Price
  • CALC $18.20
  • LTRN N/A
  • AVG Volume (30 Days)
  • CALC 32.4K
  • LTRN 170.5K
  • Earning Date
  • CALC 03-27-2025
  • LTRN 03-17-2025
  • Dividend Yield
  • CALC N/A
  • LTRN N/A
  • EPS Growth
  • CALC N/A
  • LTRN N/A
  • EPS
  • CALC N/A
  • LTRN N/A
  • Revenue
  • CALC N/A
  • LTRN N/A
  • Revenue This Year
  • CALC N/A
  • LTRN N/A
  • Revenue Next Year
  • CALC N/A
  • LTRN N/A
  • P/E Ratio
  • CALC N/A
  • LTRN N/A
  • Revenue Growth
  • CALC N/A
  • LTRN N/A
  • 52 Week Low
  • CALC $2.05
  • LTRN $2.79
  • 52 Week High
  • CALC $6.27
  • LTRN $11.99
  • Technical
  • Relative Strength Index (RSI)
  • CALC 39.62
  • LTRN 58.38
  • Support Level
  • CALC $2.37
  • LTRN $4.50
  • Resistance Level
  • CALC $2.75
  • LTRN $5.70
  • Average True Range (ATR)
  • CALC 0.22
  • LTRN 0.47
  • MACD
  • CALC 0.00
  • LTRN -0.03
  • Stochastic Oscillator
  • CALC 26.17
  • LTRN 49.26

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: